5, the CDC reported that 37% of people 75 and older say they have ever received an RSV vaccine, and 13% said they will definitely get one. Among adults 60 to 74 years old, 24% said they’d been vaccinated for RSV, and 10% said they definitely will get the shot. Cases of RSV ...
While the FDA approval is a necessary step, the CDC also needs to recommend the shots before they are available for the age group. The approval for the vaccine, Abrysvo, in adults aged 18 to 59 was based on the results from a late-stage trial in which two doses of the vacci...
RSV vaccines are available. Three RSV vaccines have been approved for older adults by the U.S. Food and Drug Administration. You only need a single dose that you can get at any time of the year, but getting the vaccine in the early fall offers the best protection for the late fall and...
Further, the CDC suggests in the statement that health care providers talk to their adult patients about any other vaccines they might need in the fall to help protect themselves against respiratory infections. Reference CDC. CDC recommends RSV vaccine for older adults. Published June 30, 2023. ...
CDC: RSV Vaccine Recommended for Older PeopleCENTERS for Disease Control & Prevention (U.S.)RESPIRATORY syncytial virus infection vaccinesOLDER peopledoi:10.1001/jama.2023.12537Harris, EmilyJAMA: Journal of the American Medical Association
Originally, Arexvy was the only FDA-approved RSV vaccine for older adults. However, since this approval, two other RSV vaccines have come to market. The Pfizer RSV vaccine, Abrysvo, is also a protein subunit vaccine. The CDC estimates the effectiveness of protein subunit RS...
"I want to remind everyone that we have one of the best vaccine safety systems in the world. We have the ability to rapidly acquire information, rapidly assess it, and act on it. We saw that during the COVID pandemic, that system is viable, and is in place," the CDC's Dr. José...
The CDC’s vaccine advisors voted unanimously to recommend RSV vaccination for all adults aged 75 years or older. They also recommended vaccination for adults aged 60 to 74 years with risk factors for severe RSV. The CDC’s vaccine advisors voted unanimously Wednesday to recommend that ...
[1] Clinicaltrials.gov, “Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above”. Available at: https://clinicaltrials.gov/study/NCT04886596 - last accessed: September 2024
The US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any mRNA shot has been authorized against a disease other than COVID-19.